Why the study?
Despite significant therapeutic improvements, relatively little is known about the complex interactions in heart failure, particularly for heart failure with preserved ejection fraction.
Key points are not available for this paper at this time.
Design
Review
This review highlights the historical progression and future directions of heart failure therapies, including pharmacological, device-based, and digital innovations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rosano et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: